aTYR PHARMA INC: cashflow_financing
| Value | {"amount": 4697000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2016-01-01 – 2016-12-31 |
| Status | current |
| Entity | aTYR PHARMA INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T12:49:28.461302+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/43e29bcd-1a3c-4c96-9cfe-9e1c197ce2dc
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-19-009381 · Open the official SEC filing →Retrieved: 2026-08-19T12:49:28.461302+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001339970/cashflow-financing/2016-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/43e29bcd-1a3c-4c96-9cfe-9e1c197ce2dc
History
- no predecessors — first report